| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910812910203321 |
|
|
Autore |
Lotman I͡U. M (I͡Uriĭ Mikhaĭlovich), <1922-1993, > |
|
|
Titolo |
Culture and communication : signs in flux : an anthology of major and lesser-known works / / by Yuri Lotman ; edited by Andreas Schönle ; translated from the Russian by Benjamin Paloff |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Boston : , : Academic Studies Press, , [2020] |
|
©2020 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-64469-389-5 |
1-64469-388-7 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (xxvi, 219 pages) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Semiotics |
Culture - Semiotic models |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
Semiotics. From Universe of the Mind -- From The Structure of the Artistic Text -- From Culture and Explosion -- Memory in a Culturological Light -- The Language of Theater -- Cultural history. The Role of Dual Models in the Dynamics of Russian Culture -- The Symbolism of Petersburg and the Problems of Semiotics of the City -- The Duel -- A Woman's World. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
"Yuri Lotman (1922-1993) was one of the most prominent and influential scholars of the twentieth century working in the Soviet Union. A co-founder of the Tartu-Moscow school of semiotics, he applied his mind to a wide array of disciplines, from aesthetics to literary and cultural history, narrative theory to intellectual history, cinema to mythology. This collection provides a stand-alone primer to his intellectual legacy in both semiotics and cultural history. It includes new translations of some of his major pieces as well as works that have never been published in English. The collection brings Lotman into the orbit of contemporary concerns such as gender, memory, performance, world literature, and urban life. It is aimed at students from various disciplines and is augmented by an introduction and notes that elucidate the relevant contexts"-- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910972032203321 |
|
|
Autore |
Nikanorova Marina |
|
|
Titolo |
Orphan Drugs in Epilepsy |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Montrouge, : JOHN LIBBEY EUROTEXT, 2014 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (90 p.) |
|
|
|
|
|
|
Collana |
|
Topics in Epilepsy ; ; v.4 |
|
|
|
|
|
|
Altri autori (Persone) |
|
JohannessenS. I |
GentonPierre |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Epilepsy -- Treatment |
Brain Diseases |
Central Nervous System Agents |
Drug Industry |
Industry |
Therapeutic Uses |
Central Nervous System Diseases |
Nervous System Diseases |
Technology, Industry, and Agriculture |
Pharmacologic Actions |
Chemical Actions and Uses |
Disease |
Anticonvulsants |
Epilepsy |
Orphan Drug Production |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
""Orphan Drugs in Epilepsy""; ""Contents""; ""Foreword""; ""Bromides""; ""Adrenocorticotropic hormone and corticosteroids""; ""Stiripentol""; ""Felbamate""; ""Rufinamide"" |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Over half of epilepsies start before the age of 20 years and nearly 25% of them are refractory. A tiny proportion of them are even labelled a rare illness (ie: one affecting less than 200,000 people in the United |
|
|
|
|
|
|
|
|
|
|
States or less than 5 out of 10,000 people in the European Union). For these patients, two problems in their management arise: In children, seizures affect an immature brain and can impact its development. It is therefore essential to treat them so that brain development continues as normally as possible. The rarity of these syndromes does not encourage the pharmaceutical industry to invest in research. Therefore, there are few drugs available. However, a few target syndromes with a particularly unfavourable diagnosis. This work outlines 6 molecules in detail that are specifically used in epileptic encephalopathies. Every aspect of these molecules is discussed, including drug development, indication, efficacy, cost, etc. Drafted by international experts in the field of epileptology, it provides all the necessary information on orphan drugs and their clinical use. |
|
|
|
|
|
| |